PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
Back to journals
Academic Journal

Journal of Personality Disorders

1 Papers Indexed in Blossom

Data updated June 16, 2026

Research Footprint

Journal of Personality Disorders has 1 tracked paper indexed in Blossom (2023) from 4 authors, most often covering Ayahuasca, across Personality Disorders.

Published Papers

Paywallindividual

Examining the Therapeutic Effect of Ceremonial Ayahuasca on Narcissistic Personality and Antagonistic Externalizing in Adults

In a sample of 314 adults, ceremonial ayahuasca use was associated with modest self-reported reductions in some narcissistic antagonism facets (lower entitlement-exploitativeness, higher leadership authority, reduced NPD proxy) lasting up to three months. Effects were small, mixed across measures and not corroborated by informants, indicating no meaningful change and highlighting the need for further targeted research, especially in high-antagonism samples with antagonism-focused therapy.

Published
April 1, 2023
Journal
Journal of Personality Disorders
Authors
Weiss, B., Sleep, C., Miller, J. D., Campbell, W. K.

Quick Facts

Papers Indexed
1
h-Index
109
Open Access
No
Publisher
Guilford Press
Country
United States
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.